ASTELLAS PHARMA INC./ JP3942400007 /
31/08/2024 13:03:59 | Chg. 0.000 | Volume | Bid13:03:59 | Ask13:03:59 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
11.135EUR | 0.00% | - Turnover: - |
11.135Bid Size: - | 11.375Ask Size: - | 20.5 bill.EUR | - | - |
Assets
|
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
2023 IFRS in mill. JPY |
||||
---|---|---|---|---|---|---|---|
Property and Equipment | 269,044 | 286,459 | 293,742 | ||||
Intangible Assets | 623,431 | 562,496 | 1.45 mill. | ||||
Long-Term Investments | - | - | 15,684 | ||||
Fixed Assets | 1.41 mill. | 1.41 mill. | 2.37 mill. | ||||
Inventories | 153,072 | 174,386 | 248,738 | ||||
Accounts Receivable | 412,258 | 452,138 | 555,028 | ||||
Cash and Cash Equivalents | 315,986 | 376,840 | 335,687 | ||||
Current Assets | 923,354 | 1.05 mill. | 1.19 mill. | ||||
Total Assets | 2.33 mill. | 2.46 mill. | 3.57 mill. |
Liabilities
|
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
2023 IFRS in mill. JPY |
||||
---|---|---|---|---|---|---|---|
Accounts Payable | 131,415 | 144,453 | 187,392 | ||||
Long-term debt | - | - | 447,738 | ||||
Liabilities to Banks | - | - | - | ||||
Provisions | 28,224 | 30,440 | 74,415 | ||||
Liabilities | 872,087 | 948,564 | 1.97 mill. | ||||
Share Capital | - | - | - | ||||
Total Equity | 1.46 mill. | 1.51 mill. | 1.6 mill. | ||||
Minority Interests | - | - | - | ||||
Total liabilities equity | 2.33 mill. | 2.46 mill. | 3.57 mill. |
Income Statement
|
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
2023 IFRS in mill. JPY |
||||
---|---|---|---|---|---|---|---|
Revenues | 1.3 mill. | 1.52 mill. | 1.6 mill. | ||||
Depreciation (total) | 28,283 | 38,436 | - | ||||
Operating Result | 155,686 | 133,029 | 25,518 | ||||
Interest Income | 1,200 | -669 | -550 | ||||
Income Before Taxes | - | - | - | ||||
Income Taxes | 32,800 | 33,647 | 7,924 | ||||
Minority Interests Profit | - | - | - | ||||
Net Income | 124,086 | 98,714 | 17,045 |
Per Share
Cash Flow
|
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
2023 IFRS in mill. JPY |
||||
---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 257,444 | 327,767 | 172,475 | ||||
Cash Flow from Investing Activities | -62,413 | -84,500 | -845,802 | ||||
Cash Flow from Financing | -216,298 | -195,623 | 614,060 | ||||
Decrease / Increase in Cash | - | - | - | ||||
Employees | 14,520 | 14,480 | - |